Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

E Mylonakis, WM Kallas… - Clinical infectious …, 2002 - academic.oup.com
The resistance of cytomegalovirus (CMV) to ganciclovir is a factor in therapeutic failure and
disease progression. The clinical significance of such resistance in solid-organ …
被引用次数：146 相关文章

Combination Antiviral Therapy for Ganciclovir-Resistant Cytomegalovirus Infection in Solid-Organ Transplant Recipients

E Mylonakis, WM Kallas, JA Fishman - Clinical Infectious Diseases, 2002 - JSTOR
The resistance of cytomegalovirus (CMV) to ganciclovir is a factor in therapeutic failure and
disease progression. The clinical significance of such resistance in solid-organ …
[PDF] researchgate.net

[PDF][PDF] Combination Antiviral Therapy for Ganciclovir-Resistant Cytomegalovirus Infection in Solid-Organ Transplant Recipients

E Mylonakis, WM Kallas… - Clinical Infectious Diseases, 2002 - researchgate.net
METHODS At the Massachusetts General Hospital (Boston), CMV-seronegative recipients of
transplanted organs from CMV-seropositive donors receive intravenous ganciclovir …

[引用][C] Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

E MYLONAKIS, WM KALLAS… - Clinical infectious …, 2002 - pascal-francis.inist.fr
Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ
transplant recipients CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

E Mylonakis, WM Kallas… - … infectious diseases: an …, 2002 - pubmed.ncbi.nlm.nih.gov
The resistance of cytomegalovirus (CMV) to ganciclovir is a factor in therapeutic failure and
disease progression. The clinical significance of such resistance in solid-organ …

Combination Antiviral Therapy for Ganciclovir-Resistant Cytomegalovirus Infection in Solid-Organ Transplant Recipients.

E Mylonakis, WM Kallas… - Clinical Infectious …, 2002 - search.ebscohost.com
Presents a study of the combination antiviral therapy for ganciclovir-resistant
cytomegalovirus infection in solid-organ transplant recipients. Procedure of the treatment of …

Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.

E Mylonakis, WM Kallas, JA Fishman - Clinical Infectious Diseases …, 2002 - europepmc.org
The resistance of cytomegalovirus (CMV) to ganciclovir is a factor in therapeutic failure and
disease progression. The clinical significance of such resistance in solid-organ …

Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients.

E Mylonakis, WM Kallas, JA Fishman - 2002 - cabidigitallibrary.org
The resistance of cytomegalovirus (CMV) to ganciclovir is a factor in therapeutic failure and
disease progression. The clinical significance of such resistance in solid-organ …

[引用][C] Combination Antiviral Therapy for Ganciclovir-Resistant Cytomegalovirus Infection in Solid-Organ Transplant Recipients

E Mylonakis, WM Kallas… - Clinical infectious …, 2002 - Oxford University Press

[引用][C] Combination antiviral therapy for ganciclovir-resistant cytomegalovirus infection in solid-organ transplant recipients

E MYLONAKIS, WM KALLAS… - Clinical infectious …, 2002 - Oxford University Press